+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Sinus floor augmentation with simultaneous placement of dental implants using a combination of deproteinized bone xenografts and recombinant human osteogenic protein-1. A histometric study in miniature pigs



Sinus floor augmentation with simultaneous placement of dental implants using a combination of deproteinized bone xenografts and recombinant human osteogenic protein-1. A histometric study in miniature pigs



Clinical Oral Implants Research 10(6): 510-521



Maxillary sinus floor augmentation with autogenous bone has become a widely accepted procedure in implant dentistry. The use of osteoconductive bone substitutes in this indication is controversial, since their use can lead to a prolonged healing time, inhomogenous ossification, foreign body reaction, migration of particles and low bone-implant contact (BIC). The purpose of this study was to examine whether the combination of an osteoinductive protein (recombinant human osteogenic protein-1 (rhOP-1 = bone morphogenetic protein-7) with natural bovine bone mineral (BioOss) would improve ossification and the bone-implant contact (BIC) in a sinus floor augmentation with simultaneous placement of implants. In this study, the maxillary sinus floors in 5 miniature pigs were augmented with 3 ml BioOss containing 420 micrograms rhOP-1 on the test side and 3 ml BioOss alone on the control side. At the time of augmentation a titanium implant (ITI) was inserted from a laterocaudal direction. After 6 months of healing the sites of augmentation were removed and examined in non-decalcified sections by microradiography, fluorescence microscopy of sequentially labelled specimens and by histometry. On both sides, significant amounts of newly-formed bone were observed. However, on the test sites, the percentage of BIC in the augmented area was 80.0% versus 38.6% on control sites. It can be concluded that the application of bone morphogenetic proteins caused a more rapid and enhanced osseointegration of simultaneously placed implants when compared to the bone substitute alone. Therefore recombinant human osteogenic protein-1 delivered by natural bone mineral has the potential to become a clinical alternative for autogenous bone grafts in sinus floor augmentation.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 047377984

Download citation: RISBibTeXText

PMID: 10740460


Related references

Sinus floor augmentation with simultaneous placement of dental implants in the presence of platelet-rich plasma or recombinant human bone morphogenetic protein-7. Clinical Oral Implants Research 15(6): 716-723, 2004

Maxillary sinus floor augmentation and dental implant placement using dentin matrix protein-1 gene-modified bone marrow stromal cells mixed with deproteinized boving bone: A comparative study in beagles. Archives of Oral Biology 64: 102-108, 2016

Sinus floor augmentation with simultaneous implant insertion using recombinant human osteogenic protein-1. Laryngo- Rhino- Otologie 80(1): 47-51, 2001

Maxillary sinus floor augmentation using the transalveolar technique with simultaneous placement of dental implants: a 5-year clinical retrospective study. Zhonghua Kou Qiang Yi Xue Za Zhi 49(3): 161-165, 2014

A clinical long-term radiographic evaluation of graft height changes after maxillary sinus floor augmentation with a 2:1 autogenous bone/xenograft mixture and simultaneous placement of dental implants. Clinical Oral Implants Research 15(3): 339-345, 2004

A 10-year clinical and radiographic study of implants placed after maxillary sinus floor augmentation with an 80:20 mixture of deproteinized bovine bone and autogenous bone. Clinical Implant Dentistry and Related Research 16(3): 435-446, 2014

Analysis of Bone Height Changes after Maxillary Sinus Augmentation with Simultaneous and Delayed Placement of Dental Implants: A Clinical and Radiographic Study. Journal of Prosthodontics 25(6): 440-445, 2016

Modified Disk-Up Sinus Reamer for Sinus Floor Elevation and Simultaneous Implant Placement: An Animal Study with Miniature Pigs. Journal of Investigative Surgery 2019: 1-10, 2019

Highly porous hydroxyapatite with and without local harvested bone in sinus floor augmentation: a histometric study in pigs. Clinical Oral Implants Research 25(7): 871-878, 2014

A prospective 1-year clinical and radiographic study of implants placed after maxillary sinus floor augmentation with synthetic biphasic calcium phosphate or deproteinized bovine bone. Clinical Implant Dentistry and Related Research 14(1): 41-50, 2012

Clinical observation on simultaneous floor bone graft of maxillary sinus and placement of hydroxylapatite-coated titanium dental implants. Hunan Yike Daxue Xuebao 21(5): 410-412, 1996

Sinus floor augmentation with recombinant human growth and differentiation factor-5 (rhGDF-5): a pilot study in the Goettingen miniature pig comparing autogenous bone and rhGDF-5. Clinical Oral Implants Research 20(2): 175-182, 2009

Hydroxyapatite bone cement for sinus floor augmentation with simultaneous implant placement. A preliminary study. Revue de Stomatologie et de Chirurgie Maxillo-Faciale 112(5): 321-322, 2011

A clinical and histological case series study on calcium sulfate for maxillary sinus floor augmentation and delayed placement of dental implants. Clinical Implant Dentistry and Related Research 14(2): 259-265, 2012

Maxillary sinus augmentation in the non-human primate: a comparative radiographic and histologic study between recombinant human osteogenic protein-1 and natural bone mineral. Journal of Periodontology 69(8): 911-919, 1998